Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 4
2005 3
2006 1
2007 1
2008 2
2009 3
2010 5
2011 4
2012 6
2013 14
2014 16
2015 16
2016 11
2017 7
2018 14
2019 13
2020 11
2021 11
2022 9
2023 4
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

137 results

Results by year

Filters applied: . Clear all
Page 1
Pronociceptive Roles of Schwann Cell-Derived Galectin-3 in Taxane-Induced Peripheral Neuropathy.
Koyanagi M, Imai S, Matsumoto M, Iguma Y, Kawaguchi-Sakita N, Kotake T, Iwamitsu Y, Ntogwa M, Hiraiwa R, Nagayasu K, Saigo M, Ogihara T, Yonezawa A, Omura T, Nakagawa S, Nakagawa T, Matsubara K. Koyanagi M, et al. Among authors: matsubara k. Cancer Res. 2021 Apr 15;81(8):2207-2219. doi: 10.1158/0008-5472.CAN-20-2799. Epub 2021 Feb 19. Cancer Res. 2021. PMID: 33608316
N-methylation underlying Parkinson's disease.
Matsubara K, Aoyama K, Suno M, Awaya T. Matsubara K, et al. Neurotoxicol Teratol. 2002 Sep-Oct;24(5):593-8. doi: 10.1016/s0892-0362(02)00212-x. Neurotoxicol Teratol. 2002. PMID: 12200190 Review.
N-terminus of Etanercept is Proteolytically Processed by Dipeptidyl Peptidase-4.
Masui S, Yonezawa A, Yokoyama K, Iwamoto N, Shimada T, Onishi A, Onizawa H, Fujii T, Murakami K, Murata K, Tanaka M, Nakagawa S, Hira D, Itohara K, Imai S, Nakagawa T, Hayakari M, Matsuda S, Morinobu A, Terada T, Matsubara K. Masui S, et al. Among authors: matsubara k. Pharm Res. 2022 Oct;39(10):2541-2554. doi: 10.1007/s11095-022-03371-2. Epub 2022 Aug 19. Pharm Res. 2022. PMID: 35986123
Clinical questions and good practice statements of clinical practice guidelines for management of kidney injury during anticancer drug therapy 2022.
Yanagita M, Muto S, Nishiyama H, Ando Y, Hirata S, Doi K, Fujiwara Y, Hanafusa N, Hatta T, Hoshino J, Ichioka S, Inoue T, Ishikura K, Kato T, Kitamura H, Kobayashi Y, Koizumi Y, Kondoh C, Matsubara T, Matsubara K, Matsumoto K, Okuda Y, Okumura Y, Sakaida E, Shibagaki Y, Shimodaira H, Takano N, Uchida A, Yakushijin K, Yamamoto T, Yamamoto K, Yasuda Y, Oya M, Okada H, Nangaku M, Kashihara N. Yanagita M, et al. Among authors: matsubara k. Clin Exp Nephrol. 2024 Feb;28(2):85-122. doi: 10.1007/s10157-023-02415-0. Epub 2023 Oct 25. Clin Exp Nephrol. 2024. PMID: 37878114 Free PMC article. No abstract available.
Complete Deletion of Slc52a2 Causes Embryonic Lethality in Mice.
Jin C, Matsui Y, Yonezawa A, Imai S, Ogihara T, Itohara K, Nakagawa S, Nakagawa T, Matsubara K. Jin C, et al. Among authors: matsubara k. Biol Pharm Bull. 2021;44(2):283-286. doi: 10.1248/bpb.b20-00751. Biol Pharm Bull. 2021. PMID: 33518683 Free article.
Serum Concentrations of Infliximab and IL-6 for Predicting One-Year Discontinuation of Infliximab Treatment Owing to Secondary Non-response in Patients with Rheumatoid Arthritis.
Masui S, Yonezawa A, Nakamura M, Onishi A, Hashimoto M, Onizawa H, Fujii T, Murakami K, Murata K, Tanaka M, Yokoyama K, Iwamoto N, Shimada T, Itohara K, Hira D, Nakagawa S, Imai S, Nakagawa T, Hayakari M, Matsuda S, Morinobu A, Terada T, Matsubara K. Masui S, et al. Among authors: matsubara k. Biol Pharm Bull. 2023;46(8):1112-1119. doi: 10.1248/bpb.b23-00192. Biol Pharm Bull. 2023. PMID: 37532562 Free article.
137 results